Skip to main content

Syn X Pharma Hires GlaxoSmithKline Sales Exec As COO

NEW YORK, June 11 - Canadian proteomics company Syn X Pharma said Monday it has appointed Rod Wilson, a former vice president for sales at GlaxoSmithKline Canada, to the position of chief operating officer.

 

Wilson will replace Eric Fonberg who was hired as chief operating officer in January. A spokesperson for Syn X was not immediately available to comment on the reason for his departure.

 

While at GlaxoSmithKline, Wilson oversaw the sales, customer operations, distribution, and business information areas of the company's Canadian operations. Prior to working at GlaxoSmithKline, Wilson held sales and marketing positions with Eli Lilly.

 

Wilson is one of several new executives Syn X has hired in the last few months. In March, the company hired a former Eli Lilly executive to serve as vice president for business development, and in Febuary the company hired a senior protein scientist from Ciphergen, the Fremont, Calif.- based protein biochip manufacturer.

 

Syn X, of Mississauga, Ontario, has developed a differential proteomics platform for identifying biomarkers associated with diabetes, cardiovascular, and central nervous system diseases. The company hopes to focus initially on developing diagnostics from its proteomics research, such as a tool for diagnosing potential stroke victims.

 

The company currently has research alliances with seven industry and academic research institutions, including the Janssen Research Foundation, Genzyme, and University of Ottawa Heart Institute Research Corporation.  

 

The Scan

Call to Look Again

More than a dozen researchers penned a letter in Science saying a previous investigation into the origin of SARS-CoV-2 did not give theories equal consideration.

Not Always Trusted

In a new poll, slightly more than half of US adults have a great deal or quite a lot of trust in the Centers for Disease Control and Prevention, the Hill reports.

Identified Decades Later

A genetic genealogy approach has identified "Christy Crystal Creek," the New York Times reports.

Science Papers Report on Splicing Enhancer, Point of Care Test for Sexual Transmitted Disease

In Science this week: a novel RNA structural element that acts as a splicing enhancer, and more.